The main objective is to explore the feasibility of Process-based Therapy in a natural mental health care setting delivered by practitioners.
In the naturalistic setting of mental health care, treatment decisions of psychotherapists are often based on theories or experience related to treatment approaches. An alternative approach to treatment decision is suggested by Process-based Therapy (PBT), which emphasizes empirical and rational criteria for the selection of intervention. It utilizes ecological momentary assessment (EMA) data, incorporates feedback from dynamic network analysis, and supports interventions based on individual network models and empirical evidence from research related to change processes. Currently, there are no data on the feasibility and acceptability of PBT in practice. The present study investigates in a naturalistic setting, whether PBT can be implemented by psychotherapists in mental health care. Furthermore, the investigators explore the acceptability and first indications of efficacy of PBT delivered in routine practice (r-PT).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
40
Intervention planning based on the use of EMA data, feedback of dynamic network analysis and matching of interventions to central nodes of the network.
Intervention planning as usual.
JWGUniversity
Frankfurt am Main, Hesse, Germany
Client Satisfaction Questionnaire (CSQ)
Treatment satisfaction , minimum value= 8, maximum value= 32, higher scores mean better outcome
Time frame: From the time of randomization until the end of treatment, assessed no later than 28 weeks
Patient attitude towards utility of EMA and networks Scale (PAUEN)
Attitude towards utility of EMA and network models, minimum value= 8, maximum value= 40, higher scores mean better outcome
Time frame: From the time of randomization until the end of treatment, assessed no later than 28 weeks
Therapist attitude towards utility of EMA and networks Scale (TAUEN)
Attitude towards utility of EMA and network models, minimum value= 6, maximum value= 30, higher scores mean better outcome
Time frame: From the time of randomization until the end of treatment, assessed no later than 28 weeks
Treatment Evaluation Inventory (TEI)
Acceptance of treatment, minimum value= 7, maximum value= 98, higher scores mean better outcome
Time frame: From the time of randomization until the end of treatment, assessed no later than 28 weeks
Attrition rate
The percentage of participants who withdraw before completing the final assessment
Time frame: From the time of randomization until the end of treatment, assessed no later than 28 weeks
Euroqol-5D (EQ-5D)
Health related quality of life, minimum health state=11111, maximum health state=55555, higher scores in health state mean worse outcome, minimum health score=0, maximum health score=100, higher scores in health score mean better outcome
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Assessed after randomization and assessed until the end of treatment, assessed no later than 28 weeks at post-treatment
Positive-Mental Health Scale (PMH)
Psychological wellbeing, minimum value=9, maximum value=36, higher scores mean better outcome
Time frame: Assessed after randomization and assessed until the end of treatment, assessed no later than 28 weeks at post-treatment
Depression Anxiety Stress Scale (DASS-10)
Psychological symptoms of distress, depressive and anxious symptoms, minimum value=0, maximum value=30, higher scores mean worse outcome
Time frame: Assessed after randomization, after completion of the EMA baseline phase (intermediate) and assessed until the end of treatment, assessed no later than 28 weeks at post-treatment (week 28)
Acceptance and Action Questionnaire Version 2 (AAQ-2)
Psychological flexibility and acceptance, minimum value=7, maximum value=49, higher scores mean worse outcome
Time frame: Assessed after randomization, after completion of the EMA baseline phase (intermediate) and assessed until the end of treatment, assessed no later than 28 weeks at post-treatment
Reflective Functioning Questionnaire (RFQ-8)
Reflective Functioning, minimum value=8, maximum value=56, higher scores on the uncertainty dimension mean worse outcome, higher scores in the certainty dimension mean better outcome
Time frame: Assessed after randomization, after completion of the EMA baseline phase (intermediate) and assessed until the end of treatment, assessed no later than 28 weeks at post-treatment
Process-based Assessment Tool (PBAT)
Variation, selection and retention of adaptive behavior, minimum value=0, maximum value=1800, higher scores mean better outcome
Time frame: Assessed after randomization, after completion of the EMA baseline phase (intermediate) and assessed until the end of treatment, assessed no later than 28 weeks at post-treatment
Cognitive-Behavioral-Therapy Skills Questionnaire (CBTSQ)
Patients use of CBT interventions, minimum value=6, maximum value=42, higher scores mean better outcome
Time frame: Assessed after randomization, after completion of the EMA baseline phase (intermediate) and assessed until the end of treatment, assessed no later than 28 weeks at post-treatment
Credibility/Expectancy Questionnaire (CEQ)
six items, divided into two subscales that capture credibility and expectancy
Time frame: Assessed after randomization (pre-treatment)
Clinical Global Impression Scale (CGI) + (CGI-I)
assesses the clinician's overall evaluation of the severity of a mental disorder and is utilized to monitor changes in symptom severity over time
Time frame: CGI assessed after randomization (pre-treatment), CGI-I assessed until the end of treatment, assessed no later than 28 weeks at post-treatment